Target
$12.57 → $12.18
Current stock research snapshot · 7/31/26 26 days old
PRMEPrime Medicine
Investment conviction●●○○○2 of 5 · current snapshot
Research target$12.18Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 7/31/26
Market cap$547MSnapshot value · 7/31/26
Research history
See all PRME changes ↗What changed
Healthspan taxonomy seed — see taxonomy_path
Prime Medicine prime editing pipeline; Q2 2026 earnings; IND/regulatory milestones for lead candidate(s); preclinical data for rare disease programs
needs primary source validation — pending deep-dive research. Placeholder: (1) thesis chain breaks on primary-source evidence, (2) named revenue/customer concentration risk, (3) margin compression or competitive displacement
Bullish — 35M short interest noted with potential BMY milestone or aatd/CF partnership; weekly chart 'tick tock'. [X search Aug 2026]
Snapshot · 7/31/26🟡 Mixed · 13F 14+/9-×0.5 · short↑0.27
Snapshot · 7/31/26